Krilogy Financial LLC Invests $1.19 Million in Tenet Healthcare Corporation $THC

Krilogy Financial LLC bought a new stake in Tenet Healthcare Corporation (NYSE:THC) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 5,714 shares of the company’s stock, valued at approximately $1,192,000.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Wealthfront Advisers LLC acquired a new position in shares of Tenet Healthcare during the third quarter worth approximately $205,000. Arista Wealth Management LLC lifted its stake in shares of Tenet Healthcare by 49.5% in the third quarter. Arista Wealth Management LLC now owns 3,624 shares of the company’s stock valued at $736,000 after buying an additional 1,200 shares in the last quarter. Candriam S.C.A. increased its position in shares of Tenet Healthcare by 42.1% during the third quarter. Candriam S.C.A. now owns 34,816 shares of the company’s stock worth $7,069,000 after acquiring an additional 10,310 shares in the last quarter. Smartleaf Asset Management LLC raised its holdings in shares of Tenet Healthcare by 94.3% in the 3rd quarter. Smartleaf Asset Management LLC now owns 542 shares of the company’s stock worth $109,000 after acquiring an additional 263 shares during the last quarter. Finally, Alps Advisors Inc. acquired a new position in Tenet Healthcare during the 3rd quarter valued at about $479,000. Institutional investors and hedge funds own 95.44% of the company’s stock.

Wall Street Analysts Forecast Growth

THC has been the topic of a number of recent research reports. Weiss Ratings upgraded Tenet Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a report on Monday, December 29th. Truist Financial reaffirmed a “buy” rating and set a $240.00 price objective (up from $225.00) on shares of Tenet Healthcare in a report on Monday, November 3rd. Royal Bank Of Canada increased their target price on shares of Tenet Healthcare from $253.00 to $277.00 and gave the company an “outperform” rating in a report on Thursday. Wall Street Zen raised shares of Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Saturday, January 31st. Finally, Jefferies Financial Group lifted their target price on shares of Tenet Healthcare from $250.00 to $265.00 and gave the stock a “buy” rating in a research report on Thursday. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and three have given a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $241.00.

Tenet Healthcare Stock Performance

Shares of THC stock opened at $232.55 on Friday. Tenet Healthcare Corporation has a 52 week low of $109.82 and a 52 week high of $235.77. The firm’s 50-day simple moving average is $198.41 and its two-hundred day simple moving average is $194.17. The firm has a market cap of $20.44 billion, a price-to-earnings ratio of 15.01, a P/E/G ratio of 0.95 and a beta of 1.44. The company has a debt-to-equity ratio of 2.18, a quick ratio of 1.64 and a current ratio of 1.76.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.08 by $0.62. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The company had revenue of $5.53 billion during the quarter, compared to analyst estimates of $5.47 billion. During the same quarter last year, the business posted $3.44 EPS. Tenet Healthcare’s quarterly revenue was up 8.9% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. As a group, equities analysts forecast that Tenet Healthcare Corporation will post 12.24 earnings per share for the current year.

More Tenet Healthcare News

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Q4 beat and strong results: Tenet reported $4.70 EPS vs. $4.08 est. and $5.53B revenue (up ~8.9% YoY); management highlighted revenue and EBITDA growth that underpins the market rally. Tenet Reports Strong Fourth Quarter and FY 2025 Results; Provides 2026 Financial Outlook
• Positive Sentiment: Raised 2026 outlook: Tenet issued EPS guidance of $16.19–$18.47 and an adjusted EBITDA target of $4.485B–$4.785B, signaling confidence in cash flow and M&A optionality. Tenet Healthcare outlines $4.485B–$4.785B 2026 adjusted EBITDA target amid structural cost initiatives and M&A focus
• Positive Sentiment: Analyst upgrade/price-target lift: Jefferies raised its price target to $265 and keeps a Buy rating, providing additional analyst support for further upside. Jefferies Raises Price Target to $265 (Benzinga)
• Positive Sentiment: Market reaction: Shares hit a new one‑year/all‑time high on the beat and outlook, indicating strong investor appetite after the results. Tenet Healthcare (NYSE:THC) Hits New 1-Year High on Better-Than-Expected Earnings
• Neutral Sentiment: Full earnings materials and call transcripts are available for deeper review (slides and transcript show drivers behind the guide and cost initiatives). Tenet Healthcare Corporation 2025 Q4 – Results – Earnings Call Presentation
• Negative Sentiment: Policy headwind: Tenet expects about a $250M hit this year from the loss of ACA subsidies, a near‑term earnings and cash‑flow headwind investors must account for. Tenet expects $250M hit from loss of ACA subsidies this year
• Negative Sentiment: Margin risk for 2026: Some analysts note the guidance midpoint implies potential pressure on 2026 EBITDA margins even as revenue guidance was lifted — monitor margin execution and cost initiatives closely. Tenet Healthcare Beats Q4 Earnings: But 2026 EBITDA Margin May Decline

Insider Activity at Tenet Healthcare

In other news, Director Nadja West sold 2,178 shares of the stock in a transaction on Monday, December 15th. The stock was sold at an average price of $197.47, for a total transaction of $430,089.66. Following the completion of the transaction, the director owned 28,480 shares in the company, valued at approximately $5,623,945.60. This represents a 7.10% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.81% of the stock is owned by corporate insiders.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.